XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 29, 2025
Dec. 28, 2024
Current assets:    
Cash and cash equivalents $ 229,356 $ 194,606
Trade receivables and contract assets, net of allowances for credit losses of $16,258 and $18,301, respectively 756,629 720,915
Inventories 290,156 278,544
Prepaid assets 129,987 103,210
Other current assets 100,230 105,796
Total current assets 1,506,358 1,403,071
Property, plant and equipment, net 1,587,069 1,604,014
Venture capital and strategic equity investments 214,026 218,350
Operating lease right-of-use assets, net 402,908 412,490
Goodwill 2,873,402 2,846,608
Intangible assets, net 655,705 723,400
Deferred tax assets 48,794 42,179
Other assets 294,104 278,233
Total assets 7,582,366 7,528,345
Current liabilities:    
Accounts payable 149,334 140,337
Accrued compensation 197,325 179,418
Deferred revenue 250,462 248,322
Accrued liabilities 242,467 232,010
Other current liabilities 211,467 194,014
Total current liabilities 1,051,055 994,101
Long-term debt, net and finance leases 2,510,754 2,240,205
Operating lease right-of-use liabilities 475,111 483,789
Deferred tax liabilities 107,268 106,960
Other long-term liabilities 196,396 195,212
Total liabilities 4,340,584 4,020,267
Commitments and contingencies (Notes 10, 12, and 14)
Redeemable noncontrolling interests 41,663 41,126
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,201 shares issued and 49,115 shares outstanding as of March 29, 2025, and 51,141 shares issued and outstanding as of December 28, 2024 512 511
Additional paid-in capital 1,978,052 1,966,237
Retained earnings 1,837,569 1,812,100
Treasury stock, at cost, 2,086 and zero shares, as of March 29, 2025 and December 28, 2024, respectively (356,551) 0
Accumulated other comprehensive loss (265,246) (317,345)
Total Charles River Laboratories International, Inc. equity 3,194,336 3,461,503
Nonredeemable noncontrolling interest 5,783 5,449
Total equity 3,200,119 3,466,952
Total liabilities, noncontrolling interests and equity $ 7,582,366 $ 7,528,345